A carregar...
Carbonyl Reductase 1 Plays a Significant Role in Converting Doxorubicin to Cardiotoxic Doxorubicinol in Mouse Liver, but the Majority of the Doxorubicinol-Forming Activity Remains Unidentified
Doxorubicin is a widely used cancer therapeutic, but its effectiveness is limited by cardiotoxic side effects. Evidence suggests cardiotoxicity is due not to doxorubicin, but rather its metabolite, doxorubicinol. Identification of the enzymes responsible for doxorubicinol formation is important in d...
Na minha lista:
| Publicado no: | Drug Metab Dispos |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The American Society for Pharmacology and Experimental Therapeutics
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7011114/ https://ncbi.nlm.nih.gov/pubmed/31955137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.119.089326 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|